thyroiditis in this transplantation setting is an important observation considering the increasing use of PBSCT in the treatment of autoimmune disorders. A 28-year-old female patient underwent allogeneic PBSCT from her HLA-identical sister for AML in first CR. CD34
given for GVHD prophylaxis. The patient developed acute GVHD III (bowel and skin) beginning 12 days postgrafts after myeloablative treatment is increasingly considered as potential treatment of severe autoimmune PBSCT. Acute GVHD was treated with prednisolone 5 mg/kg/day and ATG leading to resolution of GVHD at day diseases. This case demonstrates that even low numbers of lymphocytes are capable of transferring auto-60. She developed mild, limited chronic GVHD (oral mucosa and liver). Complete chimerism was documented immune disorders. Keywords: immune thyroiditis; transplantation of alloby RFLP. Thyroid hormone levels (FT4, TT3, TSH) before PBSCT were normal. BW at transplantation was 49 kg geneic selected PBSC; transfer of autoimmune disorders; T cell depletion (height, 168 cm). In October 1995, she presented with chronic weight loss (BW 38 kg), tachycardia (144 beats/min), temperature up to 38.4°C, high blood pressure (150/115 mmHg), and dysHyperthyroidism after bone marrow transplantation seems phagia. Immunosuppressive treatment of chronic GVHD to be a rare complication. Only five patients with immune with steroids and CsA was reduced 1 month before. Gastrothyroiditis and hyperthyroidism have been described so far. duodenoscopy and coloscopy ruled out bowel GVHD. RapThyroid disease in these patients resembled either Graves' idly progressive painful enlargement of the thyroid gland disease or Hashimoto's thyroiditis. We report a case of sevoccurred. Thyroid hormone levels revealed thyrotoxicosis ere hyperthyroidism with thyrotoxicosis due to immune at admission (TT4 386 nmol/l, TT3 102.91 pmol/l), TSH thyroiditis after allogeneic transplantation. In contrast to the was suppressed (Ͻ0.005 U/l). High levels of thyroglobulin previously reported cases our patient received a transplant Ab (Tg-Ab Ͼ6000 IU/ml), microsomal Ab (TPO-Ab 26 of CD34
+ selected PBSC. The occurrence of autoimmune IU/ml) were detected. No thyrotropin receptor Ab (TR-Ab Ͻ0.05 IU/ml) were present. Fine needle aspiration revealed a lymphocytic histiocytic thyroiditis confirming a thyroid-performed twice. Follow-up showed a decreased volume of donor and the recipient between 8 and 96 months after BMT. 3, 4, 7, 8 The current concept of the pathogenesis of the thyroid gland. Immunosuppressive treatment of cGVHD was slowly tapered. Ten months later the patient immune thyroiditis after allogeneic BMT is therefore the transfer of a clone of donor lymphocytes with antithyroidal is hypothyroid and receives hormone substitution. She has continuously gained weight (47 kg) and is now close to her activity. Similar to immune thyroiditis the transfer of insulin-dependent diabetes between HLA-identical siblings by BW at transplantation.
The stem cell donor was on l-thyroxin medication BMT has been reported.
9,10
The pathogenesis of Hashimoto's thyroiditis is, accord-(100 g/day) due to hypothyroidism at stem cell harvest. This medication had been given for 10 years. The cause of ing to current knowledge, a complex mechanism. Cytotoxic T cells play an important role in the thyroid damage in hypothyroidism is not known. Autoimmune thyroiditis with subsequent hypothyroidism is most likely. No previous thyHashimoto's thyroiditis, however a diversity of interactions are assumed. Under discussion in the injury of the thyroid roid surgery, therapy with radioactive iodine, treatment with thyrostatic drugs or lithium was present. She was in Hashimoto's thyroiditis is also complement-mediated injury. The definitive pathogenic mechanisms are uncereuthyroid prior to stem cell donation and in August 1996 (TT4 95.24 nmol/l, TT3 16.89 pmol/l, TSH 0.1 U/l, Tg-Ab tain. 11 We could prove a lymphocyte infiltration by fine needle aspiration revealing cytotoxic mediated T cell dam-12 IU/ml, TPO-Ab 1 U/ml).
age of the thyroid gland. The donor was hypothyroid and required l-thyroxine substitution at the time of stem cell harvest. There were no detectable levels of thyroid-Ab and Discussion no history of previous hyperthyroidism. Since autoimmune thyroiditis is an important cause of acquired hypothyroidHyperthyroidism due to immune thyroiditis following BMT is rare. Only six patients have been reported thus far and ism and in the context of the other reported cases previous immune thyroiditis may be suspected but definitive proof in none of these patients was the hyperthyroidism as severe as in our patient.
2-7 A summary of the reported cases is is lacking. In all previously reported cases of immune thyroiditis given in Table 1 .
In two reported cases, Graves' disease occurred in after BMT, unmanipulated bone marrow grafts were given. One patient received buffy coat transfusions. The number patients with chronic GVHD. 5, 6 Mulligan et al 6 suspected the immune thyroiditis as an organ-specific manifestation of mature lymphocytes transferred with these grafts is high and the transfer of a clone of lymphocytes with antithyroid of chronic GVHD. However, no correlation between the onset of hyperthyroidism and GVHD was observed in all activity is easily possible. In our patient immune thyroiditis occurred after transplantation of allogeneic peripheral stem other cases. In these cases thyroid disease was present in both donor and recipient. In one patient the donor precells. The graft was enriched for CD34 + cells by immunoaffinity columns. This procedure results in a 3-log depletion viously had hyperthyroidism probably due to immune thyroiditis 18 years before BMT. 2 In four cases hyperof T lymphocytes. Meanwhile several groups have evaluated this method as a T cell depletion tool to prevent thyroidism or immune thyroiditis occurred in both the polyendocrine failure -type 1 (insulin-dependent) diabetes mellitus and hypothyroidism -after allogeneic bone marrow transplantation in a patient with lymphoblastic leukaemia.
